Potassium Chloride Capsule, Extended Release
Product Images NDC 62207-914

This is a description of Potassium Chloride Extended-Release Capsules, USP. It contains 8mEq K in each 600mg capsule and is only available by prescription. The capsules are designed to be released over an 8-10 hour period, and the usual dosage is specified in the accompanying prescribing information. The medication should be stored between 20°C and 25°C and should be kept out of the reach of children. The medication is manufactured by Granules Inca Limited in Hyderabad, India, and is distributed by Granules Pharmaceuticals Inc in Chantilly, VA.*

This is a description of a medication containing Potassium Chloride in Extended-Release capsules. The capsules are designed to release the active ingredient over a period of 8-10 hours. The usual dosage information is not available here, and it is recommended to follow the accompanying prescribing information. The medication should be stored in a cool, dry place away from the reach of children. The manufacturer is mentioned as Graules Indi Limited in Hyderabad, India.*

Potassium Chloride Extended-Release Capsules, USP containing 10 mEq K designed to deliver the active ingredient over a period of 10 hours. The usual dosage should be followed as per the prescription information. The medicine should be stored in a cool, dry place, away from children. Manufactured by Granules India Limited in Hyderabad, India. The labeling information is provided in a table format.*

NDC62207-914-49 Potassium Chloride Extended-Release Capsules, USP 8 mEq are capsules containing microencapsulated KCI. They are designed to gradually release the Potassium Chloride over a 12 to 16 hour period. These capsules are not for household dispensing and a proper child-resistant container should be used. The usual dosage of the extended-release capsules can be found in the accompanying prescribing information. These capsules should be stored at temperatures of 25° C (68°t0 77° F) as defined in the USP. These capsules are manufactured by Granules India Limited for Granules Pharmaceuticals Inc. No information is available about the recommended usage of this drug.*

NOC 62207-914-43 is a prescription-only medication that comes in the form of extended-release capsules containing 8 mEq of Potassium Chloride. It is designed to release the active ingredient over an 8- to 10-hour period. The usual dosage instructions should be followed as outlined in the prescribing information, and the medication should be kept in a tight, child-resistant container at room temperature. This medication is manufactured in India by Granules India Limited and is distributed by Granules Pharmaceuticals Inc. in Chantilly, VA.*

NDC 62207-915-49 is a medication containing Potassium Chloride in extended-release capsules form. The capsules are designed to release the active ingredient over an 8 to 10-hour period. The usual dosage depends on the prescribing information provided. The medication should be dispensed in a child-resistant container and stored at 20°C to 25°C. This medication should be kept out of the reach of children. It is manufactured by Granulos India Ltd. and made in India, and is available in a bulk container of 1000 capsules.*

NDC 62207-915-57 is a prescription medicine containing Potassium Chloride in the form of extended-release capsules. Each capsule contains 10 mEq of microencapsulated KCI which releases the active ingredient gradually over an 8 to 10-hour period. The usual dosage details can be found in the accompanying prescribing information. It is advised to store these capsules in a tightly closed, child-resistant container at a temperature between 20 to 25°C (68 to 77°F), as defined by the USP. These capsules are manufactured by Granules India Limited, located at Hyderabad-500081, India, and made in NDA. The US-based manufacturing location for these capsules is Granules Pharmaceuticals Inc., located at Chantilly, VA 20151.*